Amazon.com, Inc. supported nuclear energy newcomer X-energy (XE.US) is pricing its IPO at $16-19 per share with plans to raise $750 million.
X-Energy (XE.US) announced the terms of its initial public offering (IPO) on Wednesday.
Small modular reactor developer and nuclear fuel producer X-Energy (XE.US) announced the terms of its initial public offering (IPO) on Wednesday. The company plans to issue 42.9 million shares of stock at a price range of $16 to $19 per share, raising $750 million.
X-Energy is dedicated to designing advanced nuclear reactor technology, particularly small modular reactors (SMRs), and producing nuclear fuel. Its flagship product is a high-temperature gas-cooled reactor, designed to generate electricity and heat in a modular fashion. The company is focused on developing scalable nuclear systems to meet the growing demand for electricity, including the power needs of high-energy consumption applications such as data centers.
The company, headquartered in Rockville, Maryland, was founded in 2009. In the twelve months ending on December 31, 2025, the company reported revenue of $1.09 billion. X-Energy plans to list on the Nasdaq under the ticker symbol "XE".
J.P. Morgan, Morgan Stanley, Jefferies Financial Group Inc., Moelis & Company, Cantor Fitzgerald, UBS Group AG, TD Securities, Guggenheim Securities, WR Securities, and Nomura Securities are the joint underwriters for the offering. Pricing is expected to occur on April 20, 2026.
It is worth noting that this IPO comes at a time when the United States is experiencing a new "nuclear renaissance". In 2025, e-commerce giant Amazon.com, Inc. led a $700 million private financing round for X-Energy and established a strategic partnership with them, aiming to collectively deploy over 5GW of new nuclear capacity by 2039.
Related Articles

J&T EXPRESS-W (01519) spent 23.4103 million Hong Kong dollars to repurchase 2.284 million shares on April 28th.

UNITED LAB (03933): TUL321 Capsules receive approval for new drug clinical trials by the US FDA.

LEGENDHOLDING (03396) will distribute a final dividend of 0.1 yuan per share on August 28th.
J&T EXPRESS-W (01519) spent 23.4103 million Hong Kong dollars to repurchase 2.284 million shares on April 28th.

UNITED LAB (03933): TUL321 Capsules receive approval for new drug clinical trials by the US FDA.

LEGENDHOLDING (03396) will distribute a final dividend of 0.1 yuan per share on August 28th.






